Rotterdam school of Management, Erasmus University compact logo
Photo
Lecturer
Rotterdam School of Management (RSM)
Erasmus University Rotterdam

More information

Publications

Academic (12)
  • Koopmann, B. D. M., Omidvari, A. H., Lansdorp-Vogelaar, I., Cahen, D. L., Bruno, M. J., & de Kok, I. M. C. M. (2023). The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies. International Journal of Cancer, 152(8), 1570-1580. https://doi.org/10.1002/ijc.34379

  • Mulder, S. T., Omidvari, A. H., Rueten-Budde, A. J., Huang, P. H., Kim, K. H., Bais, B., Rousian, M., Hai, R., Akgun, C., van Lennep, J. R., Willemsen, S., Rijnbeek, P. R., Tax, D. M., Reinders, M., Boersma, E., Rizopoulos, D., Visch, V., & Steegers-Theunissen, R. (2022). Dynamic Digital Twin: Diagnosis, Treatment, Prediction, and Prevention of Disease During the Life Course. Journal of Medical Internet Research, 24(9), Article e35675. https://doi.org/10.2196/35675

  • Rubenstein, J. H., Omidvari, A. H., Lauren, B. N., Hazelton, W. D., Lim, F., Tan, S. X., Kong, C. Y., Lee, M., Ali, A., Hur, C., Inadomi, J. M., Luebeck, G., & Lansdorp-Vogelaar, I. (2022). Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis. Gastroenterology, 163(1), 163-173. https://doi.org/10.1053/j.gastro.2022.03.037

  • Omidvari, A. H., Lansdorp-Vogelaar, I., de Koning, H. J., & Meester, R. G. S. (2021). Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration. PLoS ONE, 16(7 July), Article e0253893. https://doi.org/10.1371/journal.pone.0253893

  • Omidvari, A. H., Hazelton, W. D., Lauren, B. N., Naber, S. K., Lee, M., Ali, A., Seguin, C., Kong, C. Y., Richmond, E., Rubenstein, J. H., Luebeck, G. E., Inadomi, J. M., Hur, C., & Lansdorp-Vogelaar, I. (2021). The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis. Gastroenterology, 161(2), 487-494. https://doi.org/10.1053/j.gastro.2021.05.003

  • Peterse, E. F. P., Meester, R. G. S., De Jonge, L., Omidvari, A. H., Alarid-Escudero, F., Knudsen, A. B., Zauber, A. G., & Lansdorp-Vogelaar, I. (2021). Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests. Journal of the National Cancer Institute, 113(2), 154-161. https://doi.org/10.1093/jnci/djaa103

  • Rubenstein, JH., Noureldin, M., Tavakkoli, A., Hur, C., Omidvari, A., & Waljee, AK. (2020). Utilization of Surveillance Endoscopy for Barrett's Esophagus in Medicare Enrollees. Gastroenterology, 158, 773-775.e1. https://doi.org/10.1053/j.gastro.2019.10.022

  • Omidvari, A., Ali, A., Hazelton, WD., Kroep, S., Lee, M., Naber, S., Lauren, BN., Ostvar, S., Richmond, E., Kong, CY., Rubenstein, JH., Lansdorp - Vogelaar, I., Luebeck, G., Hur, C., & Inadomi, J. (2020). Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling. Clinical Gastroenterology and Hepatology, 18(9), 1961-1969. https://doi.org/10.1016/j.cgh.2019.11.058

  • Omidvari, A., Roumans, C., Naber, S., Kroep, S., Wijnhoven, B., van der Gaast, A., de Jonge, P. J., Spaander, M., & Lansdorp - Vogelaar, I. (2020). The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management. American Journal of Gastroenterology, 115(7), 1026-1035. https://doi.org/10.14309/ajg.0000000000000578

  • Gini, A., Zauber, AG., Cenin, D., Omidvari, A., Hempstead, SE., Fink, AK., Lowenfels, AB., & Lansdorp - Vogelaar, I. (2018). Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer. Gastroenterology, 154(3), 556-+. https://doi.org/10.1053/j.gastro.2017.10.036

  • Heberle, CR., Omidvari, A., Ali, A., Kroep, S., Kong, CY., Inadomi, JM., Rubenstein, JH., Tramontano, AC., Dowling, EC., Hazelton, WD., Luebeck, EG., Lansdorp - Vogelaar, I., & Hur, C. (2017). Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device. Clinical Gastroenterology and Hepatology, 15(9), 1397-+. https://doi.org/10.1016/j.cgh.2017.02.017

  • Omidvari, A., Meester, R., & Lansdorp - Vogelaar, I. (2016). Cost effectiveness of surveillance for GI cancers. Best Practice & Research in Clinical Gastroenterology, 30(6), 879-891. https://doi.org/10.1016/j.bpg.2016.09.001

Academic (1)
Internal (1)
  • Omidvari, A. (2020). Screening for and surveillance of Barrett’s esophagus: a cost-effectiveness assessment. [Doctoral Thesis, Erasmus University Rotterdam]. Erasmus Universiteit Rotterdam (EUR).

Courses

Positive Impact Seminar

  • Study year: 2024/2025
  • Code: BM11MI
  • Level: Master

Research Trajectory & Thesis

  • Study year: 2024/2025
  • Code: BMMTMI1
  • Level: Master

OLD STYLE - Research Fundamentals Course

  • Study year: 2024/2025, 2023/2024, 2022/2023
  • Code: BMRMMI
  • Level: Master

Past courses

Digital transformation in Healthcare

  • Study year: 2023/2024, 2022/2023
  • Code: BMME186
  • Level: Master, Master, Master, Master, Master

Intellectual property

  • Study year: 2023/2024
  • Code: BM03MBI
  • Level: Master

Medical innovation

  • Study year: 2023/2024
  • Code: BM02MBI
  • Level: Master

Medical innovation and Intellectual property

  • Study year: 2022/2023
  • Code: BM01MBI
  • Level: Master